TY - JOUR AU - Van Campenhout, Claude AU - Meléndez, Bárbara AU - Remmelink, Myriam AU - Salmon, Isabelle AU - D’Haene, Nicky PY - 2019 TI - Blood tumor mutational burden: are we ready for clinical implementation? JF - Journal of Thoracic Disease; Vol 11, Supplement 15 (September 29, 2019): Journal of Thoracic Disease Y2 - 2019 KW - N2 - Immunotherapy by using antibodies against the immune checkpoint inhibitor (ICI) PD-1 demonstrated objective durable responses in approximately 20% of patients with advanced non-small-cell lung cancer (NSCLC), melanoma, or renal-cell cancer (1). UR - https://jtd.amegroups.org/article/view/31221